GETCO Holding Company’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

GETCO Holding Company’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$23K	Buy	+2,199	New	+$25.8K	﹤0.01%	257

Other funds holding CTIC

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

KCG

Knight Capital Group $5.4B AUM

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

GETCO Holding Company's CTIC Position: Q2 2013 in Review

GETCO Holding Company opened a new position in CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2013: 2,199 shares worth $23K. The stake represents ﹤0.01% of the portfolio and ranks #257 among its holdings.

64 funds tracked by Wall St. Rank hold CTIC as of Q2 2013.

GETCO Holding Company held 2,199 shares of CTI BioPharma Corp. (DE) Common Stock worth $23K as of Q2 2013.
CTI BioPharma Corp. (DE) Common Stock was a new GETCO Holding Company position in Q2 2013.
CTI BioPharma Corp. (DE) Common Stock made up ﹤0.01% of GETCO Holding Company's portfolio in Q2 2013, its #257 holding.
64 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2013.

Based on GETCO Holding Company's 13F filing for Q2 2013, filed 15 Aug 2013.